Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs ORCHID PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA ORCHID PHARMA ASTRAZENECA PHARMA/
ORCHID PHARMA
 
P/E (TTM) x 94.6 42.1 224.9% View Chart
P/BV x 22.5 7.8 290.0% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 ASTRAZENECA PHARMA   ORCHID PHARMA
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-23
ORCHID PHARMA
Mar-23
ASTRAZENECA PHARMA/
ORCHID PHARMA
5-Yr Chart
Click to enlarge
High Rs3,620439 825.5%   
Low Rs2,438273 892.6%   
Sales per share (Unadj.) Rs401.2163.1 245.9%  
Earnings per share (Unadj.) Rs39.713.5 293.4%  
Cash flow per share (Unadj.) Rs46.227.0 171.5%  
Dividends per share (Unadj.) Rs16.000-  
Avg Dividend yield %0.50-  
Book value per share (Unadj.) Rs234.4168.7 139.0%  
Shares outstanding (eoy) m25.0040.82 61.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x7.52.2 346.2%   
Avg P/E ratio x76.326.3 290.1%  
P/CF ratio (eoy) x65.513.2 496.5%  
Price / Book Value ratio x12.92.1 612.6%  
Dividend payout %40.30-   
Avg Mkt Cap Rs m75,71814,522 521.4%   
No. of employees `000NANA-   
Total wages/salary Rs m2,591654 396.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m10,0306,659 150.6%  
Other income Rs m261194 134.3%   
Total revenues Rs m10,2916,853 150.2%   
Gross profit Rs m1,2491,235 101.1%  
Depreciation Rs m163548 29.7%   
Interest Rs m6329 1.9%   
Profit before tax Rs m1,341552 242.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m3480-   
Profit after tax Rs m993552 179.7%  
Gross profit margin %12.518.5 67.1%  
Effective tax rate %26.00-   
Net profit margin %9.98.3 119.3%  
BALANCE SHEET DATA
Current assets Rs m9,3595,010 186.8%   
Current liabilities Rs m4,8443,719 130.3%   
Net working cap to sales %45.019.4 232.2%  
Current ratio x1.91.3 143.4%  
Inventory Days Days4957 86.3%  
Debtors Days Days391,180 3.3%  
Net fixed assets Rs m2,0617,242 28.5%   
Share capital Rs m50408 12.3%   
"Free" reserves Rs m5,8116,478 89.7%   
Net worth Rs m5,8616,886 85.1%   
Long term debt Rs m01,488 0.0%   
Total assets Rs m11,42112,252 93.2%  
Interest coverage x213.92.7 7,982.3%   
Debt to equity ratio x00.2 0.0%  
Sales to assets ratio x0.90.5 161.6%   
Return on assets %8.77.2 121.6%  
Return on equity %16.98.0 211.2%  
Return on capital %23.010.5 218.4%  
Exports to sales %081.9 0.0%   
Imports to sales %37.437.6 99.5%   
Exports (fob) Rs mNA5,452 0.0%   
Imports (cif) Rs m3,7472,501 149.8%   
Fx inflow Rs m6125,452 11.2%   
Fx outflow Rs m3,7472,726 137.5%   
Net fx Rs m-3,1352,726 -115.0%   
CASH FLOW
From Operations Rs m583183 317.9%  
From Investments Rs m181-312 -58.0%  
From Financial Activity Rs m-245312 -78.5%  
Net Cashflow Rs m519183 283.9%  

Share Holding

Indian Promoters % 0.0 69.8 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 5.4 18.6 29.1%  
FIIs % 2.7 4.1 64.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 30.2 82.9%  
Shareholders   29,032 36,931 78.6%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on ASTRAZENECA PHARMA vs Orchid Pharma

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs Orchid Pharma Share Price Performance

Period ASTRAZENECA PHARMA Orchid Pharma S&P BSE HEALTHCARE
1-Day -0.92% 0.29% 1.18%
1-Month -4.51% -13.47% -0.75%
1-Year 57.72% 175.44% 61.82%
3-Year CAGR 20.13% -23.47% 18.16%
5-Year CAGR 21.96% 184.97% 19.79%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the Orchid Pharma share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of Orchid Pharma the stake stands at 69.8%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of Orchid Pharma.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 16.0 per share. This amounted to a Dividend Payout ratio of 40.3%.

Orchid Pharma paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of Orchid Pharma.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.